CETP mediates CE transport from HDL to LDL (or VLDL) in plasma; thus, CETP inhibition seemed an ideal strategy to increase HDL-C and decrease LDL-C as an anti-ASCVD therapy. This evidence concerns the gene CETP and atherosclerosis.